98%
921
2 minutes
20
Purpose: To investigate clinical and imaging features associated with a high nodal burden (≥ 3 metastatic lymph nodes [LNs]) and compare diagnostic performance of US and MRI in patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC).
Methods: Retrospective search revealed 239 patients with ILC and 999 with IDC who underwent preoperative US and MRI between January 2016 and June 2019. Patients with ILC were propensity-score-matched with patients with IDC. Univariate and multivariate logistic regression analyses were performed to determine factors associated with ≥ 3 metastatic LNs.
Results: 412 patients (206 ILC and 206 IDC) were evaluated. Of all patients with ILC, 27.2% (56/206) were node-positive and 7.8% (16/206) showed a high nodal burden. In multivariate analysis, the clinical N stage was the only independent factor associated with a high nodal burden in patients with IDC (odds ratio [OR] 6.24; 95% confidence interval [CI] 1.57-24.73; P = 0.009), but not in patients with ILC. Increased cortical thickness with loss of fatty hilum on US was associated with a high nodal burden in patients with ILC (OR 58.40; 95% CI 5.09-669.71; P = 0.001) and IDC (OR 24.14; 95% CI 3.52-165.37; P = 0.001), while suspicious LN findings at MRI were independently associated with a high nodal burden in ILC only (OR 13.94; 95% CI 2.61-74.39; P = 0.002).
Conclusion: In patients with ILC, MRI findings of suspicious LNs were helpful to predict a high nodal disease burden.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10549-020-06056-9 | DOI Listing |
BMC Genomics
September 2025
Key Laboratory of Grass-Feeding Livestock Healthy Breeding and Livestock Product Quality Control, Veterinary Research Institute, Inner Mongolia Academy of Agricultural and Animal Husbandry Sciences, Hohhot, 010031, China.
Background: The nematode superfamily Strongyloidea represents a prevalent group of gastrointestinal parasites in ruminants and livestock, posing substantial veterinary and economic burdens worldwide. Here we present the first mitochondrial genomic investigation for reconstructing Strongyloidea phylogeny and investigating niche-specific selection dynamics across gastrointestinal habitats (abomasum, small intestine, and large intestine). This study presents a preliminary exploration of the evolutionary adaptations of these agriculturally relevant parasites through comprehensive mitogenomic analysis.
View Article and Find Full Text PDFJ Surg Oncol
September 2025
Department of Surgical Oncology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
Background And Objectives: The current staging for gallbladder cancer (GBC) considers only the number of metastatic lymph nodes without addressing their location. This study evaluates the prognostic impact of lymph node mapping (both number and location) in node positive GBC.
Methods: Prospectively maintained operative database of operated GBC patients from April 2010 to March 2022 with positive lymph nodes was analyzed.
Clin Genitourin Cancer
August 2025
Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address:
Introduction: Lymph node involvement after radical prostatectomy (pN1) is associated with worse oncologic outcomes, yet its optimal management remains controversial. We evaluated oncologic outcomes and treatment patterns in pN1 prostate cancer.
Patients And Methods: We analyzed data from the National Cancer Database (NCDB) on men undergoing radical pN1 between 2010 and 2020.
Cancer Epidemiol
October 2025
School of Medicine and Dentistry, Griffith University, Gold Coast Campus, Gold Coast 4222, Australia. Electronic address:
Background: Cutaneous melanoma incidence is rising globally, and survival rates have improved significantly due to advances in early detection and treatment. As a result, the long-term health of melanoma survivors is gaining increasing clinical attention. One emerging concern is the development of second primary cancers (SPCs), which may result from shared risk factors, genetic susceptibility, or late effects of cancer treatment, including radiotherapy.
View Article and Find Full Text PDFDiagnostics (Basel)
August 2025
Department of Nuclear Medicine, LMU University Hospital, LMU Munich, 81377 Munich, Germany.
: In patients with metastatic castration-resistant prostate cancer (mCRPC) and osseous metastases only, Radium therapy represents a valuable therapeutic option. Bone scintigraphy (BS) is typically performed to assess metastasis load, with the BS-derived automated bone scan index (aBSI) used for response assessment. This study aimed to evaluate the prognostic value of aBSI in patients receiving three or six cycles of Ra therapy.
View Article and Find Full Text PDF